Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Equity (2016 - 2025)

Historic Return on Equity for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.13%.

  • Amphastar Pharmaceuticals' Return on Equity fell 900.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.22% for FY2024, which is 200.0% down from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Return on Equity stood at 0.13%, which was down 900.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Equity registered a high of 0.24% during Q2 2024, and its lowest value of 0.0% during Q1 2021.
  • For the 5-year period, Amphastar Pharmaceuticals' Return on Equity averaged around 0.16%, with its median value being 0.17% (2023).
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -1600bps in 2021, then surged by 1800bps in 2022.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Return on Equity stood at 0.15% in 2021, then grew by 17bps to 0.17% in 2022, then rose by 30bps to 0.22% in 2023, then decreased by -8bps to 0.2% in 2024, then plummeted by -36bps to 0.13% in 2025.
  • Its Return on Equity was 0.13% in Q3 2025, compared to 0.16% in Q2 2025 and 0.18% in Q1 2025.